Table II.
Body fat percentage in patients with and without comorbidities
| Variables | With comorbidity | Without comorbidity | P-value | ||
|---|---|---|---|---|---|
| N (%)a | BF%b | N (%)a | BF%b | ||
| DM | 167 (14.1) | 34.1 (10.4–54.6) | 1016 (85.9) | 31.1 (14.1–54.6) | < 0.001* |
| HTN | 500 (42.3) | 34.2 (15.3–54.6) | 683 (57.7) | 31.2 (10.4–52.3) | < 0.001* |
| COPD | 287 (24.3) | 31.4 (14.1–54.6) | 896 (75.7) | 32.9 (10.4–54.6) | 0.075 |
| CAD | 187 (15.8) | 32.1 (16.3–54.6) | 996 (84.2) | 32.6 (10.4–54.6) | 0.813 |
| CVD | 41 (3.5) | 32.4 (23.4–45.0) | 1142 (96.5) | 32.8 (10.4–54.6) | 0.752 |
DM – diabetes mellitus, HTN – hypertension, COPD – chronic obstructive pulmonary disease, CAD – coronary arterial disease, CVD – cerebrovascular disease, BF% – body fat percentage.
a
Data are expressed as number (%).
b
Data are expressed as median (range).
*
Statistically significant (p < 0.05).